Is Teladoc Health Stock a Buy?

Teladoc Health (NYSE: TDOC) hasn't been an easy stock for investors to hold -- its shares are down by a shocking 88% over the last three years. But few would deny that the company has a substantial amount of real value stemming from its extensive telehealth platform and massive base of subscribers.So, is this business an appealing purchase right now, or is it doomed to underperform? Let's dive in.Per the bull thesis in favor of buying Teladoc, the road to riches for shareholders will be paved by the company's economies of scale that it will be able to realize as a result of being the highest-profile telehealth operator, with around 93 million members in the U.S.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool